{"result": "(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic disease that occurs when the body cannot effectively use insulin, leading to high blood sugar levels and various health complications.)\n##\n(\"entity\"<|>HIPOPITUITARISMO<|>EVENT<|>Hypopituitarism is a condition in which the pituitary gland does not produce sufficient amounts of certain hormones, affecting various bodily functions.)\n##\n(\"entity\"<|>INSTITUTO DE INVESTIGACIÓN SANITARIA Y BIOMÉDICA DE ALICANTE<|>ORGANIZATION<|>The Institute of Health and Biomedical Research of Alicante (ISABIAL) is a research institution focused on health and biomedical studies, where Óscar Moreno Pérez coordinates research projects.)\n##\n(\"relationship\"<|>ÓSCAR MORENO PÉREZ<|>INSTITUTO DE INVESTIGACIÓN SANITARIA Y BIOMÉDICA DE ALICANTE<|>Óscar Moreno Pérez coordinates the research group on Diabetes and Associated Metabolic Diseases at ISABIAL<|>7)\n##\n(\"relationship\"<|>DIABETES<|>HIPOPITUITARISMO<|>Diabetes can be influenced by hormonal imbalances, including those caused by hypopituitarism, affecting insulin production and glucose metabolism<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Referencias:                                                                                                                            de normalidad, pero solo es un parámetro de control del tratamiento, no un objetivo del\n        • Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance L. Evaluation and treatment of adult growth hormone deficiency: An           tratamiento (respuesta C falsa).\n          Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(6):1587-609.\n        • Snyder PJ. Growth Hormone Deficiency in adults. En: Cooper DS, Martin KA, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.      Referencias:\n          uptodate.com (acceso 29 de abril de 2019).                                                                                            • López-Fernández J, Oliva García JG, Pérez Luis JM. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de\n                                                                                                                                                  Endocrinología y Nutrición; 2015. Capítulo 17. Hipopituitarismo [citado 29 de abril 2019]. Disponible en: https://manual.seen.es/\n                                                                                                                                                  article?id=55114b66-489c-4c70-8a67-2bcdac18103c\n\n\n\n74                                                                                                                                                                                                                                                                       75\n---\nNO_CONTENT_HERE\n---\nMÓDULO\n\n\n\n       2                         Diabetes\n\n\n\n          AUTORES\n          Óscar Moreno Pérez\n             Especialista en Endocrinología y Nutrición. Coordinador de la Unidad de Dia-\n             betes del Hospital General Universitariode Alicante. Coordinador del Grupo\n             de investigación de Diabetes y Enfermedades Metabólicas Asociadas del\n             Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL).\n             Profesor asociado del Departamento de Medicina Clínica de la Universidad\n             Miguel Hernández. Coordinador (2011-2014) y miembro del Grupo de Tra-\n             bajo de Diabetes, de la Sociedad Española de Endocrinología y Nutrición\n             (SEEN).\n             Experiencia en proyectos de investigación I+D+i financiados en convocato-\n             rias competitivas de administraciones o entidades públicas y privadas con\n             materialización de los proyectos finalizados en artículos originales y comu-\n             nicaciones a congresos nacionales e internacionales. Sus líneas principales\n             de investigación se centran en el desarrollo de prototipos de monitorización\n             de glucosa no invasiva, cardiovascular, diabetes tipo 2, homeostasis de la\n             insulina y riesgo cardiovascular en estados proinflamatorios.\n          Rebeca Reyes García\n             Especialista en Endocrinología y Nutrición. Doctora en Medicina y Cirugía\n             por la Universidad de Granada (2006).\n             Médico adjunto en el Servicio de Endocrinología y Nutrición del Hospital\n             Universitario Torrecárdenas y en el Servicio de Endocrinología de la Clínica\n             San Pedro, Almería.\n             Miembro del Grupo de Trabajo de Diabetes de                  la Sociedad      Española de\n             Endocrinología y Nutrición (SEEN).\n---\n                                                                                                                                                                                                            DIABETES                        2\n\n\n\n    2.1 Etiología, diagnóstico y clasificación                                                                          COMENTARIO\n                                                                                                                        El desarrollo de autoinmunidad se inicia con anterioridad al diagnóstico de diabetes y\n                                                                                                                        puede producirse con una antelación variable, desde años a meses.\n        1     ¿Qué opción es cierta con respecto a la DM1?                                                              Hay claras evidencias que relacionan los factores ambientales con la susceptibilidad para\n              A. La concordancia de la DM1 en gemelos univitelinos es muy superior a la DM2.                            desarrollar DM1. El rápido aumento de la incidencia de la enfermedad en países desarro-\n              B. Cuando el proceso autoinmunitario ha destruido el 10% de la masa de células β empieza                  llados constituye un ejemplo de la relevancia de los factores ambientales. Además, se ha\n                  a elevarse la glucosa en sangre.                                                                      observado una mayor incidencia de DM1 en otoño e invierno. Por otra parte, poblaciones\n              C. Los haplotipos DR3 y DR4 están presentes con más frecuencia en los pacientes con DM1.                  con baja incidencia en su país de origen que emigran, desarrollan la enfermedad con una\n                                                                                                                        incidencia similar a la de su país de destino. Numerosos factores ambientales se han aso-\n              D.  El proceso autoinmunitario destruye tanto las células β como las células α (productoras               ciado a DM1, pero ninguno de ellos ha sido confirmado como factor causal.                             Entre estos\n                  de glucagón) del islote pancreático.                                                                  factores se ha propuesto la dieta (gluten, leche de vaca), infecciones víricas, la vitamina D\n                                                                                                                        y el aumento de la higiene.\n              COMENTARIO                                                                                                El riesgo de desarrollar diabetes es del 0,5% en la población general; en gemelos monocigo-\n              La agregación familiar en la DM1 es poco frecuente. La tasa de concordancia entre geme-                   tos es\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ÓSCAR MORENO PÉREZ<|>PERSON<|>Óscar Moreno Pérez is a specialist in Endocrinology and Nutrition, coordinator of the Diabetes Unit at the General University Hospital of Alicante, and associated professor at the Miguel Hernández University.)\n##\n(\"entity\"<|>REBECA REYES GARCÍA<|>PERSON<|>Rebeca Reyes García is a specialist in Endocrinology and Nutrition, a doctor in Medicine and Surgery from the University of Granada, and a member of the Diabetes Working Group of the Spanish Society of Endocrinology and Nutrition.)\n##\n(\"entity\"<|>HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE<|>ORGANIZATION<|>The General University Hospital of Alicante is a healthcare institution where Óscar Moreno Pérez works as a coordinator of the Diabetes Unit.)\n##\n(\"entity\"<|>HOSPITAL UNIVERSITARIO TORRECÁRDENAS<|>ORGANIZATION<|>The Torrecárdenas University Hospital is a healthcare institution where Rebeca Reyes García works as an attending physician in the Endocrinology and Nutrition Service.)\n##\n(\"entity\"<|>CLÍNICA SAN PEDRO<|>ORGANIZATION<|>San Pedro Clinic is a healthcare institution where Rebeca Reyes García also works in the Endocrinology Service.)\n##\n(\"entity\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Spanish Society of Endocrinology and Nutrition is a professional organization that focuses on the study and treatment of endocrine and nutritional disorders.)\n##\n(\"relationship\"<|>ÓSCAR MORENO PÉREZ<|>HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE<|>Óscar Moreno Pérez coordinates the Diabetes Unit at the General University Hospital of Alicante<|>8)\n##\n(\"relationship\"<|>REBECA REYES GARCÍA<|>HOSPITAL UNIVERSITARIO TORRECÁRDENAS<|>Rebeca Reyes García works as an attending physician in the Endocrinology and Nutrition Service at Torrecárdenas University Hospital<|>8)\n##\n(\"relationship\"<|>REBECA REYES GARCÍA<|>CLÍNICA SAN PEDRO<|>Rebeca Reyes García works in the Endocrinology Service at San Pedro Clinic<|>8)\n##\n(\"relationship\"<|>ÓSCAR MORENO PÉREZ<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Óscar Moreno Pérez is a member of the Diabetes Working Group of the Spanish Society of Endocrinology and Nutrition<|>6)\n##\n(\"relationship\"<|>REBECA REYES GARCÍA<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Rebeca Reyes García is a member of the Diabetes Working Group of the Spanish Society of Endocrinology and Nutrition<|>6)\n<|COMPLETE|>"}]}